While reporting financial results for the fourth quarter on Friday, biopharmaceutical company AbbVie, Inc. (ABBV) initiated its adjusted earnings guidance for the full-year 2025, in line with estimates.
For fiscal 2025, AbbVie now projects adjusted earnings in a range of $12.12 to $12.32 per share, which excludes any impact from acquired IPR&D and milestones that may be incurred during 2025.
On average, 27 analysts polled expect the company to report earnings of $12.13 per share for the year. Analysts' estimates typically exclude special items.
Looking ahead, the company reaffirmed is expectations for high single-digit compound annual revenue growth rate through 2029, with 2024 as the base year in the compound annual growth rate calculation. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.